MSc Barbara Možina

MSc Barbara Možina
no.: 24781 source: ARIS

researcher – not employed in research organisation
  bmozinaat signonko-i.si
Edit
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
8.82
A''
0
A'
0
A1/2
0
CI10
222
CImax
174
h10
3
A1
0.02
A3
0
Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 11  222  216  19.64 
Scopus 8  260  255  31.88 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 1985 
Specialization      SI 1995 
Master's degree  M. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2003 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Research projects Legend
source: ARIS
no. Code Title Period Head
1. L3-2622  Biological markers of risk for development, progression and treatment response in asbestos related diseases   9/1/2020 - 8/31/2023  PhD Vita Dolžan   3,431 
2. J3-2527  New approaches for prediction of cardiotoxicity in breast cancer radiotherapy   9/1/2020 - 8/31/2023  PhD Tanja Marinko   2,516 
3. L3-8203  Serumski, genetski in epigenetski označevalci tveganja za nastanek, napredovanja in odgovora na zdravljenje bolezni povezanih z izpostavljenostjo azbestu (Slovene)   5/1/2017 - 4/30/2020  PhD Vita Dolžan   3,145 
4. J3-8202  Spremljanje imunskega odziva v realnem času po in situ vakcinaciji z elektrokemoterapijo in pridruženo gensko terapijo z interlevkinom-12 (Slovene)   5/1/2017 - 4/30/2020  PhD Maja Čemažar   3,878 
5. L2-4105  Razvoj programa za numerično modeliranje elektroporacije in vivo ter njegova validacija? in silico elektroporacija (Slovene)   7/1/2011 - 6/30/2014  PhD Damijan Miklavčič   5,237 
6. J3-0124  VPLIV REKOMBINANTNEGA HUMANEGA ERITROPOETINA NA IZRAŽANJE GENOV IN PRENOS SIGNALA PRI RAKU NA DOJKAH (Slovene)   2/1/2008 - 1/31/2011  PhD Nataša Debeljak   4,032 
Confirmation required
Views history
Favourite